Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
disregarded due to major methodological deficiencies
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Animals were exposed to a pyrotechnically generated atmosphere, the relevance of this to the submission substance is unclear.

Data source

Reference
Reference Type:
publication
Title:
Evaluation of the Respiratory Tract after Acute Exposure to a Pyrotechnically Generated Aerosol Fire Suppressant
Author:
Smith EA, Kimmel EC, English JH, Bowen LE, Reboulet JE & Carpenter RL
Year:
1997
Bibliographic source:
Journal of Applied Toxicology 17 (2): 95-103

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Fischer 344 rats (250 -300g) were exposed to the resulting aerosols from the pyrolysis of Spectrex Fire Extinguishant (SFE) Formulation A, a pyrotechnically generated aerosol fire suppressant, at a loading 50 or 80 g/m3 air for 15 or 60 minutes.
Exposures were conducted in a 700 L whole-body inhalation chamber, under static conditions. The chamber atmosphere was analysed for mass aerosol concentration and particle size distribution. Clinical observations were recorded throughout the exposure period. The rats were terminated 1, 6, 24 hours or 7 or 14 days post-exposure and subjected to histopathological examination, enzyme analysis and determination of wet and dry lung weights.
GLP compliance:
no
Test type:
other:
Limit test:
no

Test material

Constituent 1
Reference substance name:
Spectrix Fire Extinguishant Formulation A
IUPAC Name:
Spectrix Fire Extinguishant Formulation A
Test material form:
other: dry-powder fire retardant
Details on test material:
During fire suppression standard procedures result in unintentional release of fluorocarbons. Due to the destructive effect of fluorocarbons on atmospheric ozone, CFCs and halocarbons are being phased out and replacement fire suppressants based on dry-powder aerosols are being developed.
Spectrex Fire Extinguishant (SFE) is one of the pyrotechnically generated aerosols comprising primarily potassium perchlorate, which generates an aerosol of potassium chloride on decomposition.
The aerosol particles produced by the pyrolisation process are typically of a respirable size (typically 1-10 µm). Such particles are inhalable and can penetrate deep into the tracheobronchial tree and alveoli.

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
not specified
Details on test animals or test system and environmental conditions:
Fischer 344 rats (250 -300g)

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
whole body
Details on inhalation exposure:
The rats were exposed to the resulting aerosols from the pyrolysis of Spectrex Fire Extinguishant (SFE) Formulation A, a pyrotechnically generated aerosol fire suppressant, at a loading 50 or 80 g/m3 air for 15 or 60 minutes.
Exposures were conducted in a 700 L whole-body inhalation chamber, under static conditions.
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
>= 15 - <= 60 min
Concentrations:
50 or 80 g/m3 air
Details on study design:
The rats were terminated 1, 6, 24 hours or 7 or 14 days post-exposure.

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LC50
Effect level:
> 80 mg/m³ air
Based on:
test mat.
Exp. duration:
60 min
Remarks on result:
other: No deaths occurred at the highest exposure concentration
Mortality:
No deaths occurred.
Clinical signs:
other: Clinical signs of reaction to treatment included dyspnoea, coughing, lack of coordination and lethargy. Signs became more pronounced as the exposure duration and dose loading increased.
Gross pathology:
Macroscopic examination revealed no lesions in the trachea, lung, heart or organs in the abdominal cavity.
Animals exposed to an SFE loading of 80 g/m3 for 60 minutes developed reversible pulmonary oedema and olfactory necrosis. Protein concentrations in the bronchoalveolar lavage increased but no changes were evident in enzyme levels. Wet and dry lung weights showed no differences between treated and control groups.

Applicant's summary and conclusion

Interpretation of results:
other: not adequate for classification purposes
Conclusions:
The LC50 of the resulting aerosols from the pyrolysis of Spectrex Fire Extinguishant (SFE) Formulation A, a pyrotechnically generated aerosol fire suppressant is greater than 80 g/m3 air after 60 minutes exposure.
Executive summary:

Fischer 344 rats (250 -300g) were exposed to the resulting aerosols from the pyrolysis of Spectrex Fire Extinguishant (SFE) Formulation A, a pyrotechnically generated aerosol fire suppressant, at a loading 50 or 80 g/m3 air for 15 or 60 minutes.

Exposures were conducted in a 700 L whole-body inhalation chamber, under static conditions. The chamber atmosphere was analysed for mass aerosol concentration and particle size distribution. Clinical observations were recorded throughout the exposure period. The rats were terminated 1, 6, 24 hours or 7 or 14 days post-exposure and subjected to histopathological examination, enzyme analysis and determination of wet and dry lung weights.

No deaths occurred. Clinical signs of reaction to treatment included dyspnoea, coughing, lack of coordination and lethargy. Signs became more pronounced as the exposure duration and dose loading increased. Macroscopic examination revealed no lesions in the trachea, lung, heart or organs in the abdominal cavity.

Animals exposed to an SFE loading of 80 g/m3 for 60 minutes developed reversible pulmonary oedema and olfactory necrosis. Protein concentrations in the bronchoalveolar lavage increased but no changes were evident in enzyme levels. Wet and dry lung weights showed no differences between treated and control groups.